Internal Medicine, Infectious Disease · Long Beach, CA
NPI
1447208418
Since 2006
Specialty
Internal Medicine, Infectious Disease
Code 207RI0200X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
2699 Atlantic Ave
Long Beach, CA, 90806
Phone (562) 426-3333
Groups this clinician bills Medicare through
Medicare paid, 2024
$38K
481 services
Medicare patients, 2024
117
Average age 74
Drug cost, 2024
$3.8M
3,142 prescriptions
Company payments, 2025
$178
From 2 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Greg L Strayer was code 99214 (office e&m - established), 129 times for 66 patients. In total Greg L Strayer billed 481 services in 30 codes, and Medicare paid $38K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-01-12.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 129 | 66 | $98.02 | $13K |
| 99213 Office E&M - Established | Office | 111 | 50 | $71.18 | $7,901 |
| 99442 Telephone Services | Office | 22 | 16 | $78.30 | $1,723 |
| 99223 Hospital E&M - Initial | Facility | 16 | 13 | $142.28 | $2,276 |
By year: 2022 $149K for 9,483 services; 2023 $146K for 5,926 services; 2024 $38K for 481 services.
Medicare prescription drug claims, 2024
In 2024, the drug Greg L Strayer prescribed most often to Medicare patients was Biktarvy (Bictegrav/Emtricit/Tenofov Ala), with 261 prescriptions and refills. In total Greg L Strayer wrote 3,142 Medicare prescriptions that cost $3.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Biktarvy Bictegrav/Emtricit/Tenofov Ala | 261 | 297 | 32 | $1.2M |
| Atorvastatin Calcium Generic | 174 | 402 | 41 | $1,512 |
| Genvoya Elviteg/Cob/Emtri/Tenof Alafen | 129 | 171 | 16 | $691K |
| Fluconazole Generic | 95 | 111 | 22 | $3,265 |
| Triumeq Abacavir/Dolutegravir/Lamivudi | 91 | 103 | 11 | $377K |
| Doxycycline Hyclate Generic | 86 | 98 | 26 | $1,897 |
| Juluca Dolutegravir/Rilpivirine | 83 | 129 | 14 | $437K |
| Descovy Emtricitabine/Tenofov Alafenam | 78 | 98 | 11 | $208K |
| Testosterone Generic | 76 | 90 | 13 | $8,180 |
| Amoxicillin-Clavulanate Potass Amoxicillin/Potassium Clav | 68 | 70 | 19 | $1,070 |
| Trazodone Hcl Generic | 60 | 81 | 12 | $574 |
| Tivicay Dolutegravir Sodium | 60 | 60 | Under 11 | $122K |
| Tamsulosin Hcl Generic | 52 | 115 | Under 11 | $1,302 |
| Rosuvastatin Calcium Generic | 50 | 96 | Under 11 | $560 |
| Finasteride Generic | 49 | 113 | Under 11 | $873 |
Brand drugs: - claims; generic drugs: 2,120 claims; opioid claims: 27.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Greg L Strayer $178 ($178 in general payments such as food, travel and fees) from 2 companies. The largest payer was Gilead Sciences, Inc. with $154.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.